Lupin has today, 30 June 2025, executed a Business Transfer Agreement (BTA) for transfer of its Over-the-Counter Consumer Healthcare Business (OTC Business) to LUPINLIFE Consumer Healthcare (LCHL), a wholly owned subsidiary of the Company, on a slump sale basis.
In terms of the BTA, the said transaction has been completed, and transfer of OTC Business will be effective from 01 July 2025.